Dynamics of the cytokine response to Mycobacterium ulcerans during antibiotic treatment for M. ulcerans disease (Buruli ulcer) in humans

Clin Vaccine Immunol. 2009 Jan;16(1):61-5. doi: 10.1128/CVI.00235-08. Epub 2008 Nov 12.

Abstract

We have studied the evolution of the gamma interferon (IFN-gamma) and interleukin 10 (IL-10) responses after Mycobacterium ulcerans sonicate stimulation of whole blood from patients with early M. ulcerans lesions during treatment with rifampin and streptomycin for 8 weeks. Among the 26 patients, secretion of IFN-gamma increased during treatment, with a significant increase at 4 weeks and a further increase after 8 weeks overall. The increase was more rapid in patients with large or ulcerative lesions, becoming significant by 4 weeks. For small lesions, there was only a minor increase, which did not reach significance. There was no significant change in the median IL-10 response during antibiotic therapy, and there was no inverse correlation between IFN-gamma and IL-10 responses. These results demonstrate that an IFN-gamma secretory response to M. ulcerans developed, independently of IL-10 secretion, in patients whose M. ulcerans disease healed during antibiotic therapy.

MeSH terms

  • Adolescent
  • Adult
  • Anti-Bacterial Agents / therapeutic use*
  • Buruli Ulcer / drug therapy*
  • Buruli Ulcer / immunology*
  • Child
  • Female
  • Humans
  • Interferon-gamma / blood*
  • Interleukin-10 / blood*
  • Male
  • Middle Aged
  • Mycobacterium ulcerans / immunology*
  • Rifampin / therapeutic use
  • Streptomycin / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Interleukin-10
  • Interferon-gamma
  • Rifampin
  • Streptomycin